Evidence map›Paper›PMID 38891959›Full record

ArticleInternational journal of molecular sciences2024

FLT3-TKD Measurable Residual Disease Detection Using Droplet Digital PCR and Clinical Applications in Acute Myeloid Leukemia.

Eric Wenlong Li, Ngoc Yen Kim Tran, Derek McCulloch, Michael Krigstein, Alberto Catalano, Jad Othman, Edward Abadir, Cheryl Smith, Harry Iland

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eric Wenlong LiInstitute of Hematology, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.ORCID 0000-0002-6688-8511
Ngoc Yen Kim TranMolecular Hematology Laboratory, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.
Derek McCullochInstitute of Hematology, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.
Michael KrigsteinDepartment of Hematology, St Vincent's Hospital, Sydney, NSW 2010, Australia.ORCID 0000-0002-6964-9591
Alberto CatalanoMolecular Hematology Laboratory, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.
Jad OthmanFaculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia.
Edward AbadirInstitute of Hematology, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.
Cheryl SmithMolecular Hematology Laboratory, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.
Harry IlandInstitute of Hematology, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tyrosine kinase domain of the FMS-Like tyrosine kinase 3 (

Indexed as

fms-Like Tyrosine Kinase 3Leukemia, Myeloid, AcuteMutationNeoplasm, ResidualPolymerase Chain ReactionAdultAgedFemaleHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedFLT3 protein, humanfms-Like Tyrosine Kinase 3acute myeloid leukemiaclonal evolutionFMS-like tyrosine kinasemeasurable residual diseaseprecision oncologytreatment monitoring

Identifiers

PMID38891959
PMCPMC11171966

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.